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ABBREVIATIONS 
 
Inj.:                - Injection 
i.v:                 - intravenous 
i.e :                - that is 
eg:             - Example 
G:         - Gauge 
%:                  - percentage 
mg :              - milligram 
Kg:             - kilogram 
ml:                 - millilitre 
B.P:             - Blood Pressure 
SpO2:        - Oxygen saturation of arterial blood 
ECG:        - Electrocardiogram 
NIBP:        - Non Invasive Blood Pressure 
H.R:           - Heart Rate 
SBP:             - Systolic Blood Pressure 
DBP:        - Diastolic Blood Pressure 
MAP:      - Mean Arterial Pressure 
CVS:           - Cardiovascular System 
CNS:     - Central Nervous System 
ASA PS:       - American Society of Anaesthesiologist Physical Status  
min:           - minutes 
SD:              - Standard Deviation 
wt:   - weight 
Ht:  - Height 
NA - Neonatal Apgar 
EPH - Ephedrine 
cm - centimetre 
COMP - complications 
MR - Muscle Relaxation 
PS - Patient Satisfaction 
GA - Gestational Age 
OC - Obstetric Code 
IND - Indication 
2% LIG - 2% Lignocaine 
DUR - Duration of surgery 
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INTRODUCTION 
 The use of neuraxial anaesthesia has gained popularity in recent time 
over general anaesthesia for caesarean section.  Neuraxial anaesthesia has 
several advantages, including a reduced risk of failed intubation and 
aspiration of gastric contents, avoidance of depressant drugs and the mother 
can remain awake and enjoy the birthing experience
1,2
.  It has been found 
that blood loss is reduced under regional anaesthesia for caesarean section
3
.
 
 The combined spinal-epidural technique(CSE), first reported in 
cesarean section in 1984
4
, has recently gained popularity.  Spinal anaesthesia 
has a very rapid onset of action and provides a dense neural blockade but 
finite duration of action and the drawbacks are, that they carry a high 
incidence of nausea, vomiting, hypotension
5
 and even fetal acidemia.  
Epidural anaesthesia is more titratable, may produce less hemodynamic 
swings
6
, can be used for postoperative analgesia but slow onset, patchy 
blockade, catheter migration, large volume of local anaesthetic requirement 
are the drawbacks. 
 CSE offers benefits of both spinal and epidural anaesthesia and 
decreases their failure rates when used alone.  Both techniques have a failure 
rate of 2-5% even with experienced practitioners
6
, when used separately.  
The chance of both techniques failing at the same time, if combined, would 
be 0.16%. 
 CSE is shown to produce a physiologically denser block than either 
technique performed separately
7
. 
 CSE technique allows the use of smaller doses of local anaesthetics, 
which in turn reduces the incidence of high spinal block and hypotension
8
. 
 This study was designed to evaluate the optimum dose of intrathecal 
hyperbaric bupivacaine 0.5% with epidural lignocaine in combined spinal 
epidural technique for caesarean section that can produce adequate 
anaesthesia without causing significant hemodynamic changes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM OF THE STUDY 
 This study aims to evaluate the optimum dose of intrathecal 
hyperbaric bupivacaine with epidural lignocaine in combined spinal epidural 
technique for caesarean section to achieve adequate anaesthesia with 
hemodynamic stability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 COMBINED SPINAL EPIDURAL ANALGESIA 
 
Combined spinal-epidural (CSE) technique for providing pain relief 
for labor and anaesthesia for caesarean section has gained popularity.  It 
involves the identification of the epidural space and insertion of the epidural 
catheter and an initial placement of an intrathecal dose of local anaesthetic, 
opioid or both, everything as a single procedure
9
. 
It combines the advantages of rapid onset and the reliability of 
blockade obtained by subarachnoid blockade with the flexibility given by 
the epidural catheter placed and avoids the disadvantages, when used 
seperately
10
. 
HISTORY: 
  Soresi was the first person to perform Combined Spinal Epidural 
technique in 1937. 
 Cerelaru used separate spaces for each component in 1979 
 Brownridge in 1981 advised the use of CSE in caesarean section. 
 Carrie in 1984 described needle thru needle technique. 
 Dr. Morgan in 1993 introduced CSEA(combined spinal epidural 
analgesia) for labor – walking epidurals. 
 
 
The combined spinal epidural technique.  
Typically, an epidural needle is inserted in the epidural space (top left) and a 
spinal needle is inserted through it (top middle). Because of the presence of 
air in the epidural space, the pencil-point spinal needle may deform the dura 
considerably before puncturing it (top right). After injection through the 
spinal needle, it is withdrawn, an epidural catheter is inserted (bottom left), 
and the epidural needle is withdrawn (bottom rigbt). 
 
 
 
 
EQUIPMENT: 
 EPIDURAL NEEDLE: 
  Tuohy needle with bent tip – 16G or 18G, 8cm/10cm long shaft. 
 Epidural catheter – 16G or 18G catheter with single hole at the end 
or closed end with side holes at multiple levels.  A 0.2 micrometer 
filter at proximal end to prevent contamination by bacteria and 
injection of particulate matter thru the catheter. 
SPINAL NEEDLE: 
  Fine gauge needles (24G -27G) with a pencil point tip (sprotte or 
whitacre) 
8cm tuohy needle – 120 mm spinal needle 
10cm tuohy needle – 150 mm spinal needle  
 Spinal needle protrusion of 1.7cm beyond the epidural needle is 
considered optimal. 
 
 
 
 
 
 
  
COMBINED SPINAL EPIDURAL NEEDLE 
 
 
 
 
 
CSE TECHNIQUES: 
1. SINGLE PASS: 
  Soresi  in 1931 
 Needle introduced into the epidural space and a dose of local 
anaesthetic is injected and the needle further introduced into the 
subarachnoid space where further dose of local anaethetic is 
deposited. 
 Not used nowadays 
 No longevity of the block 
2. NEEDLE THROUGH NEEDLE: 
16G or 18G epidural needle is used to identify the epidural 
space.  Spinal needle of size 24G to 27G is then introduced via the 
epidural needle, till dural piercement is felt.  Spinal needle stylet is 
then removed.  Cerebrospinal fluid needs to be visualized in the hub 
of the spinal needle.  Injection of local anaesthetic agent is done.  
Spinal needle is taken out, leaving the epidural needle in situ.  About 
3.5cm of the epidural catheter is placed in the epidural space.  
Epidural catheter secured with sterile tapes and used to prolong pain 
relief once the spinal anesthesia worns off. 
 3. NEEDLE THROUGH NEEDLE (BACKEYE+): 
Epidural needles, with backeye on the curve, specially designed 
for allowing spinal needle introduction in a straight line, tip coming 
out through the backeye, entering the subarachnoid space.  The 
epidural catheter then travels along the curved part of the epidural 
needle and the tip is positioned cephalad. 
4. LOCKING NEEDLE THROUGH NEEDLE: 
It has locking device to stabilize the spinal needle with the 
epidural needle, after identifying the epidural space, which provides 
stability to the spinal needle. 
5. SEPARATE NEEDLES THROUGH SEPARATE 
INTERSPACES: 
Epidural catheter and spinal needle are introduced separately at 
two different interspaces.  Possibility of catheter injury by the spinal 
needle tip cannot be ruled out. 
6. SEPARATE NEEDLES THROUGH SAME INTERSPACES: 
Epidural catheter is placed first followed by spinal needle 
insertion and then the subarachnoid drug administration. Provides 
good patient satisfaction. 
7. COMBINED NEEDLE: 
This avoids the friction, supposed to occur while using needle 
through needle technique and separates the epidural and spinal 
components. 
8. DUAL CATHETER TECHNIQUE: 
Spinal and epidural catheterization can be done seperately.  
They have the possibility of catheter entanglement, cauda equine 
syndrome and accidental subarachnoid injection of high volume of 
drugs, mistaking spinal for epidural catheter, that might result in total 
spinal anaesthesia. 
 
 
 
 
 
 
 
 
 
 
 
SPINAL ANAESTHESIA ALONE 
 ADVANTAGES: 
  Rapid onset 
 High reliability than epidural  
 Dose requirement reduced, prevents toxicity 
 End point of needle placement is definite. 
 
 DISADVANTAGES: 
  No top-up facilities available to prolong the blockade 
 As dura is deliberately breached, the risk of postdural puncture 
headache is high. 
 
 
 
 
 
 
 
 
EPIDURAL ANAESTHESIA ALONE 
 ADVANTAGES: 
  Used widely 
 Familiarity of the technique 
 Epidural catheter allows topup doses to produce alteration or 
prolongation of the blockade 
 Hypotension occurs slowly when compared to subarachanoid 
blockade. 
 Postdural puncture headache is uncommon, unless accidental dural 
puncture occurs. 
 
 DISADVANTAGES: 
  Slow onset  
 Sometimes asymmetrical or patchy  
 Huge volume of local anaesthetic agents needed 
 Certain nerve roots are very difficult to block 
 
COMBINED SPINAL EPIDURAL ANAESTHESIA CAN THUS 
PRODUCE… 
 Rapid induction of anaesthesia 
 The quality of pain relief is better 
 Low dose of local anaesthesia required 
 Epidural catheter can prolong and optimize spinal block 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLICATIONS OF CSE TECHNIQUE: 
 Technically difficult 
 Extensive blockade 
This may be due to  
- Bolus of epidural local anaesthetic agent on the spinal 
component 
- The transfer of epidural drugs across the dural 
membrane 
- accidental migration of epidural catheter tip into the 
intrathecal space 
o epidural bolus of anesthetic agent can extend intrathecally 
administered drug, only while the subarachanoid blockade is 
developing (13 minutes) 
 Postdural puncture headache 
 Meningitis 
 Neurological sequele rare 
 
 
PREGNANCY AND REGIONAL ANAESTHESIA 
 
EFFECTS OF PREGNANCY ON SPINAL ANAESTHESIA 
TECHNICAL CONSIDERATIONS 
 Enhancement of lumbar lordosis causes reduced vertebral inter-
spinous gap creating technical difficulty. 
 Widening of pelvis results in a head down tilt, when a parturient is in 
the lateral position.  This may increase the rostral subarachnoid spread 
of hyperbaric solution when injection is made with patient in the 
lateral position. 
  Apex of thoracic kyphosis is at a higher level, thus increasing the 
cephalad spread of local anaesthetic. 
 
 
 
 
 
 
 
 
  
 
 
CSE IN OBSTETRICS 
 
 
 
 
EFFECT OF PREGNANCY ON SPINAL ANAESTHETIC DOSE 
REQUIREMENTS 
 Pregnancy enhances the spread of hyperbaric local anaesthetic 
solution in the subarachnoid space resulting in 25% reduction in the 
segmental dose requirement.  This decrease is attributed to following factors: 
 Reduction of spinal cerebrospinal fluid volume, which accompanies 
distension of vertebral venous plexus. 
 Enhanced neural susceptibility to local anaesthetics. 
 Inward displacement of intervertebral foraminal soft tissue, resulting 
from increased abdominal pressure 
 Increased rostral spread caused by the widening of pelvis. 
 Higher level of the apex of thoracic kyphosis during late pregnancy. 
 
 
 
 
 
 
 
 
PHARMACOLOGY OF BUPIVACAINE 
 Bupivacaine is an amide local anaesthetic agent.  It belongs to the 
homologous series of n-alkyl substituted pipecholyl xylidines.  It was first 
synthesized by Ekenstam in 1957 and was used clinically in 1963.  It is 
produced for clinical use as a racemic mixture containing both ‘S’ and ‘R’ 
forms in equal proportion.  It is supplied as a hydrochloride salt. 
 
CHEMICAL STRUCTURE: 
 
 
 
 1-butyl-n-(2,6-dimethyl phenyl) -2-piperidine decarboxamide 
hydrochloride monohydrate.   
 
 
 
 
 
PHYSIO-CHEMICAL PROFILE
11
: 
 Molecular weight   -  288 
 pKa     - 8.1 
 Plasma protein binding  -  95% 
 Partition coefficient  - 28 (lipid solubility) 
 T ½     - 210 min 
 Clearance    - 8.3 l/min 
 
MECHANISM OF ACTION: 
 Like all the other local anaesthetics, it inhibits Na channels.  It 
decreases or prevents large transient increase in permeability of the cell 
membranes to Na ions that follows depolarization of the membrane and 
thereby blocks the nerve conduction.  It also reduces the permeability of the 
resting nerve membrane to potassium ions as well as sodium ions and hence 
has got a stabilising action on all excitable membranes. 
 
 
 
 
 
 
EFFECTS: 
  Local – nerve blockade 
 Regional – pain, temperature, touch, motor power and vasomotor 
tone supplied by the nerves are blocked. 
 Systemic – effects due to systemic absorption or accidental 
intravenous administration. 
It is 4 times more potent than lignocaine but the onset of action is 
slower.  The duration of action is longer.  Sensory block is more 
marked than the motor block. 
SYSTEMIC EFFECTS: 
CNS: 
 Can produce 
 Circumoral numbness, metallic taste 
 Tinnitus, light headedness, dizziness 
 Confusion, slurred speech 
 convulsions 
 
 
 
CVS: 
 depresses automaticity and contractility of the heart 
 slows conduction of cardiac action potential as prolongation of PR 
and QR intervals on ECG. 
 Re-entrant phenomenon and ventricular arrhythmias 
 Results mostly from high lipid solubility 
 R-enantiomer is more toxic than S-enantiomer 
 Pregnancy increases cardiotoxic effects of bupivacaine 
KINETICS: 
 Rapidly absorbed from the site of injection 
 Peak systemic concentration – 5 to 30 minutes after administration 
 Duration of action – 360 to 720 minutes 
 Metabolism in liver – dealkylation to pipecoloxylidine, aromatic 
hydroxylation 
 Excretion – 5% by kidney as unchanged drug and rest as 
metabolites 
 
 
PREPARATION: 
 0.25%, 0.5% solutions in 10, 20 ml vials, respectively 
 5mg/ml (0.5%) bupivacaine with 80 mg dextrose (to increase 
baricity) in 4 ml ampoules for subarachnoid injection (baricity – 
1.0207) 
USES: 
 Central neuraxial blocks 
 For local infiltration subcutaneously 
 Peripheral nerve blockade 
CONTRAINDICATIONS: 
 Known hypersensitivity to amide local anaesthetics 
 Intravenous regional anaesthesia(IVRA) 
MAXIMAL DOSE: 
 2.5 mg/kg body weight and the strength used is 0.25 – 0.75% with or 
without adrenaline (1:200000 or 1:400000)
11
.  Adrenaline does not prolong 
its effect, but reduces its toxicity 
 
 
 
PHARMACOLOGY OF LIGNOCAINE 
 Lignocaine is the most commonly used local anaesthetic agent.  It is a 
tertiary amide and was first synthesised in 1943 in Sweden.  It was first used 
by Gordh in 1948
11
. 
CHEMICAL STRUCTURE: 
 
PHYSIO-CHEMICAL PROFILE: 
 Molecular weight    -  234 
 pKa      - 7.9 
 Plasma protein binding   -  64% 
 Partition coefficient   - 2.9 (lipid solubility) 
 T ½      - 96 min 
 Clearance     - 12.6 l/min 
MECHANISM OF ACTION: 
 Like all the other local anaesthetics, it inhibits Na channels.  It 
decreases or prevents large transient increase in permeability of the cell 
membranes to Na ions that follows depolarization of the membrane and 
thereby blocks the nerve conduction.   
 EFFECTS: 
  Local – nerve blockade 
 Regional – pain, temperature, touch, motor power and vasomotor 
tone supplied by the nerves are blocked. 
 Systemic – effects due to systemic absorption or accidental 
intravenous administration. 
 
 
SYSTEMIC EFFECTS: 
 
CNS: 
 Low plasma concentration produces numbness of tongue and 
circumoral area.  As plasma concentration increases, it produces 
restlessness, vertigo, tinnitus followed by drowsiness before seizure occurs.  
Seizures are followed by CNS depression, which may be accompanied by 
hypotension and apnea. 
 
 
 
CVS: 
A therapeutic concentration 1.5 – 6 microgram/ml of lignocaine can 
produce the following effects 
 Depression of slow spontaneous depolarization, suppresses 
automaticity without affecting the conduction velocity.  
Automaticity induced by stretch, hypoxia or catecholamines can 
also by suppressed by lignocaine. 
 Shortening of action potential period and effective refractory 
period of purkinjee and ventricular cells.  Thus it has got 
stabilizing effect on the heart. 
KINETICS: 
 IV injection – t ½ - 7 to 10 mins within the first hour, due to rapid 
distribution into various tissues.  After the initial phase, the t ½ is 90-120 
mins.  Absorption is slow in regional anaesthesia
11
.  
 
METABOLISM AND EXCRETION: 
 The principle metabolic pathway is oxidative dealkylation in the liver 
to monoethylglycine xylidine then to xylidine.  Monoethylglycine xylidine 
has approximately 80% of the action of lignocaine protecting against cardiac 
arrhythmias.  This has prolonged elimination half life.  Xylidine has 
approximately 10% of the activity of lignocaine. 
PREPARATION: 
 0.5% for infiltration with epinephrine 1:200000 to 1:400000 
 4% for topical analgesia, in surgery of throat, larynx, pharynx etc. 
 For nerve block and extradural block 1.5-2% with epinephrine 
 For corneal analgesia 4% - this causes no mydriasis, 
vasoconstriction or cycloplegia 
 For urethral analgesia 1-2% jelly 
 For tracheal tube 5% as an ointment 
 
USES: 
 Central neuraxial blocks 
 For local infiltration subcutaneously 
 Peripheral nerve blockade 
CONTRAINDICATIONS: 
 Known hypersensitivity to amide local anaesthetics 
 
 
 
REVIEW OF LITERATURE 
 
1.    Shou-Zen Fan et al12 have compared four different 
doses of intrathecal hyperbaric bupivacaine combined with epidural 
lignocaine for caesarean section.  A total of 80 parturients were taken 
into the study.  They were divided into four groups by random 
allocation.  Depending on the group to which they belong, they 
received 0.5ml, 1ml, 1.5ml or 2ml of 0.5% bupivacaine intrathecally.  
Sensory level of blockade was checked every 3 minutes till 15 
minutes.  If Thoracic level-4(T4) sensory blockade was not achieved 
by 15 minutes, epidural 2% lignocaine was supplemented by 
increments of 3ml every 3 minutes, till T4 level was achieved.  The 
results were analysed on the basis of the intial level of sensory 
blockade achieved, epidural requirements, complications like 
vomiting, shivering, dyspnea etc.    They have concluded that 
injecting 5 mg of hyperbaric bupivacaine intrathecally combined with 
epidural lidocaine can provide an effective and rapid onset of 
anaesthesia for caesarean section with minimal adverse effects. 
 
 
 
2.          Ranasinghe J S et al6 conducted a retrospective study to 
evaluate the significance of combined spinal epidural technique for 
cesarean deliveries.  The study reviewed cesarean deliveries that were 
done under CSE technique, in their institution over 6 months.  
Successful CSE was defined as the absence of administering general 
anesthesia to the parturients during cesarean delivery.  99.4% success 
rate was observed for CSE technique.  They have concluded that 
combined spinal epidural anaesthesia was a great improvement to 
single shot spinal or continuous epidural anaesthesia by providing 
reliable and safe regional anaesthesia for the parturients undergoing 
caesarean delivery. 
 
3.    Roofthooft E et al13 studied the effect of low dose 
intrathecal  bupivacaine in reducing the incidence of maternal 
hypotension and providing adequate anesthesia for cesarean delivery.  
Intrathecal bupivacaine of about 5 to 7mg provided adequate 
anesthesia for cesarean deliveries.  They have concluded that low dose 
spinal anaesthesia as a part of combined spinal-epidural technique is a 
very valuable tool in improving maternal and fetal outcome during 
anaesthesia for caesarean section. 
 
 4.    Leo S et al14 studied the effects of using low-dose 
intrathecal bupivacaine in Combined spinal epidural method for 
cesarean section.  60 parturients, who were posted for elective 
cesarean section, were randomized to three groups.  Hyperbaric 
bupivacaine of 7mg, 8mg and 9mg was deposited intrathecally for 
parturients in group 7, 8 and 9 respectively.  All parturients, 
irrespective of their group, received morphine 100mcg intrathecally 
and Hydroxy ethyl starch of 15ml/kg given intravenously while 
starting the CSE technique.  When sensory level blockade of T4 was 
reached, surgery was allowed to start.  The clinical outcomes were 
monitored and recorded.  In their study, they have concluded that 
lowest dose of spinal bupivacaine (7mg) provided equally rapid onset 
and effective anaesthesia for caesarean section while reducing the 
occurrence of hypotension when compared with 8 and 9 mg. 
 
 
 
 
 
5.    Choi D H et al15 compared combined spinal-epidural 
with epidural anaesthesia for cesarean delivery.  64 parturients posted 
for elective cesarean delivery were randomly dividen into two groups.  
CSEA group received 1.5 to 1.6 cc of 0.5% bupivacaine heavy 
intrathecally, which was followed by 10 cc of 0.5% bupivacaine plain 
epidurally, 10 minutes after the intrathecal injection.  EA group had 
20 to 25 cc of 2% lignocaine along with fentanyl 100mg,  0.1 cc of 
0.1% epinephrine and 8.4% NaHCO3 1.5 cc.  the two groups were 
compared based on the anesthetic quality, intraop and postop 
problems.  Intraop analgesia, motor blockade and good muscle 
relaxation were better with CSEA group than the EA group. They 
have concluded that, when combining the main spinal and the 
supporting epidural anaesthesia, CSEA achieves greater efficacy and 
less side effects than the pH adjusted epidural anaesthesia in caesarean 
delivery. 
 
 
 
 
 
6.    Titti thoren et al16 compared sequential combined 
spinal-epidural anesthesia with spinal anesthetic technique for 
cesarean delivery.  42 patients posted for cesarean delivery were 
randomly assigned into two group.  First group received spinal 
anesthesia 12.5mg of 0.5% bupivacaine intrathecally.  Second group 
received 7.5mg of 0.5% bupivacaine intrathecally and additional dose 
of epidural 2% lignocaine was administered, if necessary, to get a 
sensory block level of T4.  The time taken, from the starting of 
regional technique to the initiation of surgery and till the time of 
delivery, was noted.   They have found that the sequential CSE 
technique was proved to be safe and as effective as spinal anaesthesia 
for caesarean delivery.  There is a risk of hypotension with both the 
techniques, although it is more precipitous after conventional spinal 
anaesthesia. 
 
 
 
 
 
 
7.    Marc Van De Velde et al17 studied the effects of 
different doses of spinal hyperbaric bupivacaine on maternal 
hemodynamic changes in the combined spinal epidural anesthetic 
technique.  50 parturients undergoing cesarean delivery were 
randomly allocated into two groups.  The first group received 9.5mg 
of 0.5% bupivacaine with 25 mcg sufentanyl.  The second group 
received 6.5mg of 0.5% bupivacaine with 25 mcg sufentanyl 
intrathecally.  Various outcomes visual analogue scoring, 
hemodynamic changes, etc., were monitored and recorded.  They have 
concluded that small dose spinal anaesthesia with bupivacaine 
(6.5mg) along with sufentanil (25 microg) better maintains the 
patient’s hemodynamics, in addition to providing adequate 
anaesthesia. 
 
8.    Ben David B et al18 studied the effects of low dosage of 
bupivacaine along with fentanyl as an adjuvant intrathecally for 
cesarean section.  32 parturients posted for cesarean section were 
divided randomly  into two groups.  First group received 10 mg of 
0.5% plain bupivacaine intrathecally and the second group received 5 
mg of 0.5% plain bupivacaine along with 25 mcg of fentanyl.  
 Intraop hemodynamics, the need for the inotropes/vasopressors 
and certain other parameters were monitored and recorded.   They 
have concluded that bupivacaine 5 mg with fentanyl 25 microg 
provided adequate spinal anaesthesia for cesarean section with less 
incidence of hypotension, vasopressor need and nausea than spinal 
anaesthesia with 10mg bupivacaine. 
 
9.    Langesaeter E et al19 compared low dose and high dose 
spinal anaesthesia along with phenylephrine infusion for cesarean 
deliveries.  Eighty parturients, who were posted for elective cesarean 
section, were divided into four groups.  First group received 7mg of 
0.5% bupivacaine intrathecally and the second group received the 
same along with low infusion of phenylephrine(0.25mcg/kg/min).  
Third group received 10mg of 0.5% bupivacaine intrathecally and the 
fourth group received the same along with low infusion of 
phenylephrine(0.25mcg/kg/min).  All patients received 4mcg of 
sufentanyl, in addition, intrathecally.  Hemodynamics were monitored 
and recorded.  They have found that low dose bupivacaine along with 
an infusion of phenylephrine and adequate co-hydration preserves the 
hemodynamics better during spinal anaesthesia for cesarean section. 
 
10.   Beale  N et al20 studied the effects of the epidural volume 
extension on the intrathecally administered drug during cesarean 
section.  They have estimated the ED50 of intrathecal bupivacaine 
along with 25 mcg fentanyl for cesarean section to be 6.1mg and at 
such doses, Epidural Volume Extension(EVE) doesn’t seem to 
produce reliable reductions in dosing along with intrathecal 
bupivacaine. 
 
11.   Farida Ithnin et al21 compared the level of blockade 
produced by Combined spinal-epidural technique with the single shot 
spinal technique.  Thirty women posted for elective cesarean section 
were randomly allotted into two groups.  Both the groups received 2cc 
of 0.5% bupivacaine intrathecally.  In CSE group, the epidural space 
was identified by loss of resistance technique using 2cc of air and the 
epidural catheter was not placed.  The maximum sensory blockade 
achieved in both the groups were noted and compared.  It was found 
that CSE technique without epidural catheterisation or administration 
of epidural drug resulted in a significantly higher sensory blockade 
level than the single shot spinal technique when the same amount of 
local anaesthetic agent was used intrathecally. 
 
12.   Danelli G et al22 underwent a study to evaluate the 
lowest adequate dose of intrathecal hyperbaric bupivacaine for 
cesarean delivery.  24 parturients posted for elective cesarean delivery 
received CSE anesthesia.  The intrathecal dose of hyperbaric 
bupivacaine was based on the height of the patient.  Initially, for the 
first patient, 0.075mg/cm height of 0.5% bupivacaine was given 
intrathecally.  When the sensory block level of T4 was achieved, the 
dosage for the next patient was reduced by 0.01mg/cm height.  They 
showed that 0.06mg/cm height was the dose of intrathecal hyperbaric 
bupivacaine that provides good spinal anesthesia in 95% of the 
parturients posted for cesarean section. 
 
 
13.   Subedi A et al23 studied the effects of the height and 
weight on intrathecal bupivacaine for cesarean delivery.  100 women 
posted for elective cesarean delivery were randomly allocated into 
two groups.  First group received the adjusted dose of intrathecal 
bupivacaine according to the height and weight of patients using 
Harten’s dose chart that was created from Caucasian parturients and 
the second group received 2.2ml of 0.5% hyperbaric bupivacaine 
intrathecally.   
The time for achieving T5 sensory block level, hemodynamic 
variables, neonatal outcome and certain other parameters were 
observed and noted.  They have found that the dose adjustment 
significantly decreased the bupivacaine dosage with an added 
advantage of less incidence of hypotension and good neonatal 
outcome. 
14.   Sivevski A et al24 studied the effects of low dose of 
intrathecal hyperbaric bupivacaine along with fentanyl for cesarean 
deliveries.  40 parturients posted for elective cesarean delivery, were 
randomly allocated into two groups.  The first group received 13.5mg 
of plain bupivacaine 0.5%.  The second group received 9mg of 
isobaric bupivacaine 0.5% with 25 mcg fentanyl intrathecally.  
Hypotension, surgical relaxation and certain other parameters were 
monitored and recorded.  Though sensory blockade and motor 
blockade were very intense with the plain bupivacaine group, the 
incidence of hypotension and vomiting were also very high in this 
group, when compared to the bupivacaine-fentanyl group.  So, they 
concluded that bupivacaine 9 mg along with 20 mcg fentanyl 
produced adequate spinal anesthesia for cesarean section with less 
incidence of hypotension and vasopressor need while ensuring 
excellent surgical anesthesia. 
 15.   Vanhelder T et al25 studied the role of CSE in managing 
parturients with valvular heart defects.  They have presented a case of 
successful anaesthetic management of a parturient with moderate 
mitral stenosis and aortic insufficiency.  They have concluded that 
carefully planned regional (CSEA) anaesthetic technique was safely 
used both for labor and caesarean section in pregnant patients with 
valvular heart disease.. 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
 This study was conducted at the Govt. Kasturba Gandhi Hospital for 
Women & Children, Madras Medical College, Triplicane, Chennai-5, 
between January 2012 to March 2012 on 80 patients of ASA physical status 
I and II posted for elective caesarean section.   
This study was started after ethical committee approval and after 
obtaining written informed consent from all the patients involved in this 
study. 
 
STUDY DESIGN: 
 Prospective, randomized, double blinded study. 
 
 
GROUPS: 
 The patients were divided randomly into four groups and each group 
containing 20 patients 
 
 
 
 
  
 GROUP A: 
Patients in this group received 0.5ml of 0.5% hyperbaric 
bupivacaine intrathecally. 
  
GROUP B: 
Patients in this group received 1 ml of 0.5% hyperbaric 
bupivacaine intrathecally. 
  
GROUP C:   
Patients in this group received 1.5ml of 0.5% hyperbaric 
bupivacaine intrathecally. 
  
GROUP D:   
Patients in this group received 2 ml of 0.5% hyperbaric 
bupivacaine intrathecally. 
 
 
 
 
SELECTION OF CASES 
 INCLUSION CRITERIA: 
• Age         : 18 years and above 
• Weight   : BMI < 30 Kg/m2 
• Height     : >145 cm 
• Surgery  : Elective 
• American Society of Anaesthesiologist Physical Status     (ASA 
PS) : I & II 
• Who have given valid informed consent 
 EXCLUSION CRITERIA: 
• Not satisfying inclusion criteria. 
• Patients posted for emergency surgery 
• Lack of written informed consent 
• If the epidural catheter failed to thread through the tuohy needle 
or the procedure took more than 15 mins 
• Abnormal coagulation profile/local sepsis or any other 
contraindication for spinal/epidural anaesthesia  
 
 
 
 
PRE-ANAESTHETIC EVALUATION: 
 Patients selected for the study are evaluated thoroughly, which 
involved 
 HISTORY 
- Of underlying medical illness/co-morbidity 
- Previous surgeries in the past 
- Last oral intake 
- Any drug allergies 
 
 PHYSICAL EXAMINATION  
- General condition 
- Height 
- Weight 
- Vital signs – BP, PR, SpO2 
- Systemic examination – CVS, RS, CNS, abdomen, spine and 
cranium 
- Airwary assessment 
 INVESTIGATIONS 
- Hemoglobin concentration 
- Complete blood count 
- Renal function test  
o blood urea 
o serum creatinine  
o serum electrolytes 
- Blood sugar 
- Urine routine  
o Albumin 
o  Sugar 
o deposits 
- Bleeding time, clotting time 
- Blood grouping and typing 
- Electrocardiogram 
 
*  Patients satisfying inclusion criteria were explained about the 
procedure and the nature of the study. 
*  Written informed consent obtained from all the patients in 
their own language. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PREPARATION OF THE PATIENT: 
 After assessing the patient, an intravenous line started under aseptic 
precautions with 18 G cannula in the assessment room.  Premedication given 
with Inj. Ranitidine 50mg and Inj. Metacloperamide 10mg IV, half an hour 
before surgery. 
 Patient shifted to operation theatre in left lateral position.  Preloading 
was done with 20ml/kg of ringer Lactate over 15 minutes.  Baseline pulse 
rate, blood pressure, arterial oxygen saturation(SpO2), respiratory rate and 
fetal heart sounds were noted. 
 
 
 
 
 
 
 
 
 
 
 
 
EQUIPMENTS: 
 The spinal tray (autoclaved) used for performing the combined spinal 
epidural technique contained the following equipments. 
1. Graduated 2ml syringe 
2. No. 22G hypodermic needle 
3. No. 18G hypodermic needle 
4. No. 25G spinal needle – Quincke 
5. No. 18G epidural needle 
6. No. 20G epidural catheter 
7. 5ml syringe with freely moving plunger 
8. 5ml loss of resistance (LOR) syringe 
9. Skin towel 
10. Galley pot with swabs 
11. Sponge holding forceps 
DRUGS: 
 Bupivacaine 0.5% hyperbaric solution – 4ml ampoule 
 Lignocaine 2% with adrenaline (1:200000) solution 
 PERFORMING THE COMBINED SPINAL EPIDURAL 
BLOCKADE: 
 The patient was placed in lateral position on a horizontal operating 
table.  The back of the patient was cleaned with povidone iodine and spirit.  
The excess of spirit wiped using a dry gauze. 
 The area of blockade was draped with sterile towel.  L2-L3 space was 
selected for performing epidural catheterization and L3-L4 space was 
selected for subarachnoid blockade.  L2-L3 space identified and epidural 
space identified using 18G epidural needle through loss of resistance 
technique.  Epidural catheter threaded through that needle and tip placed 
5cm cephalad.  Epidural catheter secured using tapes. 
 L3-L4 space identified and dural tap was performed using 25G spinal 
needle.  After free flow of CSF, 0.5% bupivacaine was injected (0.5, 1, 1.5, 
2 ml each according to their respective group) at a rate of 0.2ml/second.   
Immediately, the patients were turned on their back to supine position 
and a wedge placed under right gluteal region.  Based on the level of sensory 
blockade achieved at 5
th
 minute, epidural topup given with 2% lignocaine 
with adrenaline(1:200000) 3cc every 3 minutes till sensory level T4(thoracic 
segment 4) was achieved.  6 liters of Oxygen given through face mask, till 
extraction of the baby.  Observations were recorded. 
OUTCOME MEASURES: 
 
SENSORY BLOCK: 
 Assessment of loss of temperature sensation done immediately after 
the intrathecal injection was made and continued every 15 seconds 
 Onset of sensory block was kept as the time taken from intrathecal 
injection to loss of temperature sensation, as assessed by a cotton 
piece soaked in surgical spirit, at T4 level 
 If sensory level of T4 was not achieved by 5th minute, 2% lignocaine 
with adrenaline epidural topup given 3cc every 3 minutes till T4 
sensory level was achieved. 
 
 
 
 
 
 
 
 
 
 VITAL SIGNS: 
 Pulse rate, systolic and diastolic blood pressure, SpO2, respiratory rate 
were recorded every 5 minutes throughout the intra-operative period. 
 Hypotension,  defined as fall of systolic BP 20% from the baseline or 
systolic BP of <90mm Hg whichever occurs first, was managed with 
rapid infusion of IV fluids and Inj. Ephedrine 6mg increments 
 Bradycardia defined as Heart rate <60/min and was managed with Inj. 
Atropine 0.01mg/kg IV(if resistant to inj.ephedrine given for 
hypotension) 
 Respiratory depression defined as RR<8/min or SpO2<92%, which 
was managed with bag and mask ventilation or intubation and IPPV if 
necessary. 
QUALITY OF SURGICAL ANAESTHESIA: 
 Excellent – no complaints of pain anytime during the surgery 
 Good – minimal pain or discomfort – to be treated with Inj. 
Pentazocine 0.5mg/kg IV 
 Poor – GA needs to be administered 
 
 NEONATAL APGAR SCORE: 
PARAMETERS 0 1 2 
HEART RATE Absent <100 >100 
RESPIRATORY 
EFFORTS 
Absent Irregular, slow, 
gasping or 
shallow 
Crying, robust 
MUSCLE TONE Absent  Some flexion of 
extremities  
Active 
movement 
CRY No cry grimace Active crying 
COLOUR Cyanotic Acrocyanosis 
Trunk pink 
pink 
 
 
 
 
 
 
 
 
 
OBSERVATION AND RESULTS 
 The study was conducted at Govt. Kasturba Gandhi Hospital for 
Women & Children, Madras Medical College, Triplicane, Chennai-5.  80 
patients were included in the double blinded randomized controlled study.  
The patients were divided into four groups.  Patient in group A received 
0.5ml, group B receieved 1 ml, group C received 1.5ml and group D 
received 2ml of 0.5% bupivacaine intrathecally.  Depending upon the level 
of sensory block achieved at 5
th
 minute of intrathecal injection, 2% 
lignocaine given epidurally, to achieve a sensory block level of T4. 
 
STATISTICAL ANALYSIS: 
 The four groups were matched in respect of their age, height and 
weight by ANOVA (Analysis of  Variance).  The difference between them, 
were interpreted by the Post hoc test of Bonferroni.  Similarly, 2% 
Lignocaine used, Ephedrine administration, Neonatal Apgar at 1
st
 and 5
th
 
min and duration of surgery were compared between groups by ANOVA 
and interpreted the difference by  Post hoc test of Bonferroni.  
 
 
 
The sensory level of blockade achieved and the complications like 
dyspnea, shivering and vomiting were categorized and interpreted by ‘Z’ test 
of proportions. The above statistical procedures were performed by the 
statistical package IBM SPSS statistics 20. The P - values less than 0.05 
(P<0.05) were treated as significant in two tail condition.   
 
DEMOGRAPHIC DATA: 
 The four groups were comparable in respect to their age, weight and 
height.  There was no statistical difference among the four groups. 
Table-1. Matching of the four groups according to the age. 
Group Mean SD ANOVA “F” Df Signific 
1 25.4 2.6 
0.089 3, 76 P>0.05 
2 25.1 3.0 
3 25.2 3.2 
4 25.3 3.1 
The mean ages of four groups were shown in the above table-1. The four 
groups were not significantly differed in respect of the age. 
 
 
 
  
Table-2. Matching of the four groups according to the height. 
Group Mean SD ANOVA “F” df Signific 
1 155.8 2.8 
0.116 3, 76 P>0.05 
2 156.6 2.7 
3 156.0 2.1 
4 155.8 3.1 
 
The mean height of the four groups were shown in the above table-2. The 
four groups were not significantly differed in respect of the Height (P>0.05) 
 
 
 
 
 
 
 
 
 
 
 
 
Table-3. Matching of the four groups according to the weight. 
Group Mean SD ANOVA “F” Df Signific 
1 55.8 2.7 
2.469 3, 76 P>0.05 
2 55.2 2.5 
3 55.2 2.3 
4 55.4 2.0 
 The mean weight of the four groups were shown in the above table-3. 
The four groups were not significantly differed in respect of the weight 
(P>0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
DURATION OF SURGERY AND BASELINE BP: 
 There was no statistical significance among the groups in terms of 
duration of surgery and baseline systolic blood pressure.  They are 
comparable. 
 
Table-4. Matching of the four groups according to their base SBP. 
 
Group Mean SD ANOVA “F” df Signific 
1 119.0 9.4 
0.270 3, 76 P>0.05 
2 121.0 8.3 
3 119.6 8.4 
4 118.7 9.0 
 The baselines SBP of four groups were matched in the above table-4. 
The mean SBP of four groups were not significantly differed between them 
(P>0.05). 
 
 
 
 
 
 
Table-5. Comparison of surgery duration between the four groups. 
Group Mean SD ANOVA “F” df Signific 
1 65.2 4.9 
2.469 3, 76 P>0.05 
2 63.9 6.8 
3 60.8 8.5 
4 60.6 5.3 
 The duration of surgery between four groups were compared in the 
above table-4. The mean duration of four groups were not significantly 
differed between them (P>0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
LEVEL OF SENSORY BLOCKADE: 
 Level of sensory blockade was assessed at 5
th
 minute after intrathecal 
injection of 0.5% bupivacaine.   
The median level of sensory blockade achieved by Group A, B, C and 
D are T12, T6, T4 and T4 respectively and they were shown to be significant 
statistically with a P value <0.001. 
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GROUPS 
NO. OF 
PATIENTS 
GRAPH 1.  SENSORY BLOCK HEIGHT AT 5
TH
 MINUTE OF 
INTRATHECAL INJECTION  
Table-6.Sensory level of blockade at 5th Min 
Level Group,A=2.5,B=5,C=7.5,D=10 Total χ2/ / 
Signi 1.00 2.00 3.00 4.00 
 
L1 6 0 0 0 6 122.000 
T12 12 0 0 0 4 P<0.001 
T10 2 1 1 0 12  
T8 0 2 2 0 42  
T6 0 12 0 0 12  
T4 0 5 17 20 4  
Total 20 20 20 20 80  
Median T12 T6 T4 T4   
 
 The above table -6 describes the level of Sensory blockade at 5th 
minute. Groups 1, 2, 3 and 4 were significantly associated with T12, T6, T4, 
T4 respectively (P<0.001). 
 
 
 
 
 
EPIDURAL TOPUP REQUIREMENTS: 
 2% lignocaine administered epidurally, to attain a sensory block level 
of T4, was compared among the groups. 
 2% lignocaine was administered only in Groups A, B and C as group 
D achieved sensory level of T4 in all the patients. 
 Group A with mean lignocaine use of 12ml was differed significantly 
from all other groups (p<0.001) 
 Group B with mean lignocaine use of 4.5ml was differed significantly 
from all the other groups (p<0.001) 
 Group C and D were not differed significantly (p>0.05).  group C & 
D are comparable in respect to the lignocaine requirement. 
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GRAPH 2.  AVERAGE AMOUNT OF LIGNOCAINE 2% USED 
EPIDURALLY  
Table-7.  2% Lignocaine administration between the four groups 
 
Group Mean Std. 
Deviation 
ANOVA 
‘F’ 
df Significa
nce 
Significantly differed 
groups 
 
1 12.0 1.7    All differed except 3 and 4 
2 4.5 3.2     
3 1.2 3.1 102.897 3,  76 P<0.001  
4 0.0 0.0     
 
 
 
 
 
 
 
 
 
 
 
 
 
EPHEDRINE ADMINISTRATION: 
 Ephedrine administration to treat hypotension was compared among 
the groups. 
 Group A with a mean ephedrine usage of 10.8mg was differed 
significantly from groups B & C (p<0.001) but not group D. 
  Group D with a mean ephedrine usage of 11.7mg was differed 
significantly from groups B & C (p<0.001) but not group A.   
 Group B with a mean ephedrine usage of 1.2mg was differed 
significantly from groups A, C & D (p<0.05).   
 Group A & D were comparable in respect to the ephedrine 
administration. 
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GRAPH 3.  AVERAGE AMOUNT OF EPHEDRINE USED 
INTRAOPERATIVELY 
Table-8.  Ephedrine administration between the four groups 
 
Group 
Mean SD ANOVA 
‘F’ 
df Significance Significantly differed 
groups 
 
1 10.8 3.7    
All differed except 1 and 
4 
2 1.2 3.1     
3 5.7 4.6 31.098 3,  76 P<0.001  
4 11.7 4.1     
 
 
 
 
 
 
 
 
 
 
 
 
 
COMPLICATIONS: 
 Certain complications like vomiting, dyspnea, shivering were 
compared among the groups. 
 Vomiting occurred in Group C & D with 20% and 35% of patients 
respectively, which was statistically insignificant(p>0.05).  Group C 
and D were comparable with respect to the occurrence of vomiting. 
 The incidence of shivering in Groups A, B & C are 50%, 5% & 5% 
respectively.  Group A differed significantly from Group B & C in 
respect to the incidence of shivering (p<0.001).  Shivering was 
significantly associated with Group A. 
 Dyspnea occurred only in one patient in Group D. 
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COMPLICATIONS 
NO. OF 
PATIENTS 
GRAPH 4.  INTRAOPERATIVE COMPLICATIONS  
GROUPS 
Table-9. Complications. 
 
Complications Group 1 Group 2 Group 3 Group 4 
No. % No. % No. % No. % 
Dyspnea 0 0.0 0 0.0 0 0.0 1 5.0 
vomiting 0 0.0 0 0.0 4 20.0 7 35.0 
Shivering 10 50.0 1 5.0 1 5.0 0 0.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OTHER PARAMETERS: 
 The quality of surgical anaesthesia rated as good, moderate or poor 
and the neonatal apgar at 1
st
 and 5
th
 minute after birth were compared and 
there was no statistical significance among the groups.   
Table-10. NA administration at different time interval between the four 
groups 
Variabl
e 
 Group Mean S D ANOVA 
‘F’ 
df Signifi
cance 
Significantly 
differed groups 
NA1 
Min 
 
 
 
1 5.4 0.5     
2 5.6 0.5     
3 5.4 0.5 .704 3,  76 P>0.05 Nil 
4 5.45 0.5     
NA5 
Min 
 
 
1 8.45 0.5     
2 8.6 0.5 .585 3,  76 P>0.05 Nil 
3 8.45 0.5     
4 8.6 0.5     
 
 
 
 
 
DISCUSSION 
 Till today, spinal anaesthesia is the most versatile block available and 
is being used for various surgeries on the lower half of our body.  Spinal 
anaesthesia is widely used for cesarean deliveries. 
 Conventionally, 10mg of 0.5% bupivacaine is used intrathecally for 
cesarean delivery.  This results in greater hemodynamic instability and 
respiratory depression. 
 Combined spinal epidural was introduced by Brownridge in the year 
1981 for cesarean section.  CSE technique allows the use of low dose 
intrathecal bupivacaine, which resulted in less hemodynamic instability.  It 
had an added advantage of prolonging the anaesthesia through the epidural 
catheter.  Moreover parturients can be rendered postop pain relief, which 
made the technique more popular. 
 Low dose intrathecal bupivacaine in CSE technique offers better 
analgesia and hemodynamic stability, which allows its use in parturients 
with cardiac disease. 
This study compared four different doses of intrathecal bupivacaine in 
combined spinal epidural technique to evaluate the optimum dose of 
intrathecal bupivacaine with epidural lignocaine in CSE technique for 
cesarean section  
 
LEVEL OF SENSORY BLOCKADE: 
 Sensory blockade level (sensation to cold) necessary for a caesarean 
section is T4.  Both groups C & D i.e, with 7.5mg & 10 mg of 0.5% 
bupivacaine attained T4 level at 5
th
 minute after intrathecal injection.  With 
2.5mg of 0.5% bupivacaine, the mean level achieved was T12 and with 5mg 
of 0.5% bupivacaine the mean level achieved was T6. 
 This correlated with the study done by Shou-Zen Fan et al
12
, where 
they compared in the similar way and the sensory block heights produced by 
2.5, 5, 7.5 & 10mg were T11, T9, T5 & T4 respectively. 
 The result also correlates with the study done by Roofthoft E et al
13
, 
where 5-7mg of 0.5% bupivacaine intrathecally was sufficient to provide 
effective anaesthesia, which is similar to our study, where 5mg of 
bupivacaine achieved a mean sensory block level of T6.   
 
 Adequate level of sensory blockade(T4) achieved by 7.5mg 
bupivacaine intrathecally in 85% of the patients was supported by the study 
done by Leo S et al
14
, in which the time taken to achieve T4 level in 7mg, 
8mg and 9 mg groups of 0.5% bupivacaine were similar in all the groups, 
indicating that 7mg was enough to achieve adequate level of anaesthesia in 
caesarean section. 
 Even 6.6mg of hyperbaric bupivacaine with sufentanyl as an adjuvant 
produced sensory block level of T4 without epidural supplementation in 
more than 80% of the patients involved in the study conducted by Marcel P 
Vercauteran et al
26
, which strongly correlates with the results of our study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EPIDURAL TOPUP REQUIREMENTS: 
 2% lignocaine epidural topup requirement was more in Group A 
(2.5mg) requiring 12ml and minimal with group B(5mg) requiring 4.5ml.  
Group C & D i.e, 7.5mg & 10 mg groups rarely required epidural topups. 
 This correlated with shou-Zen Fan et al
12
 study, where 2.5, 5, 7.5 & 
10 mg of 0.5% bupivacaine intrathecally required an epidural topup doses of 
2% lignocaine of about 22ml, 10.1ml, 1.2ml & 0ml respectively.  
Though the amount of 2% lignocaine required in their study was 
larger than our study, the ratio of 2% lignocaine used among the groups 
correlated well with our study(2:1). The difference in amount of 2% 
lignocaine required might be due to the demographic pattern being different 
in each areas, where the studies were conducted. 
 6.6mg of hyperbaric bupivacaine with 25 mcg fentanyl intrathecally 
was studied in caesarean section by Marcel P Vercauteran et al
26
.  Even at 
such low doses, sensory block level of T4 was achieved without the need for 
epidural topup in more than 80% of the study group, which strongly 
correlates with this study where little/no supplementation of epidural 
lignocaine was required in 5mg(4.5ml of lignocaine) and 7.5mg(1.2 ml of 
lignocaine) groups. 
 
 
COMPLICATIONS: 
HYPOTENSION: 
 The occurrence of hypotension was assessed among the groups 
 All the patients (100%), who received 2.5mg of 0.5% bupivacaine had 
hypotension because of high dose requirement of 2% lignocaine 
epidurally. 
 All the patients (100%), who received 10mg of 0.5% bupivacaine also 
had hypotension 
 In patients, who received 7.5mg of o.5% bupivacaine, the incidence of 
hypotension was 70%. 
 In patients, who received 5 mg of o.5% bupivacaine, the incidence of 
hypotension was less 15%. 
 
This correlated with the study by Shou-Zen Fan et al
12
, where the 
incidence of hypotension was 5%, 5%, 35% and 50% in 2.5mg, 5mg, 
7.5mg & 10mg  of 0.5% bupivacaine groups respectively.  
 
 
 
 
 5mg bupivacaine group had good hemodynamic stability with 
minimal side effects in this study correlates well with the study done by 
Roofthooft et al
13
, where intrathecal bupivacaine between 5mg and 7mg 
was found to produce effective anaesthesia for caesarean section in CSE 
technique with improved hemodynamic stability. 
 7mg bupivacaine provided adequate anaesthesia for cesarean delivery 
with reduced incidence of hypotension when compared to 8mg and 9mg 
groups in the study done by Leo S et al
14
, which is similar to our study 
results. 
 5 mg bupivacaine with fentanyl was shown to produce effective 
anaesthesia with less hypotension, vasopressor requirements and nausea 
than spinal anaesthesia with 10 mg bupivacaine, in the study conducted 
by David B et al
18
.  This correlated well with our study results.   
 The study done by Langesaeter E et al
19
 also supports our study 
results, where better hemodynamic stability was achieved with less 
incidence of hypotension in parturients, who received 7mg spinal 
bupivacaine , when used along with low dose infusion of phenylephrine 
and minimal co-hydration. 
 
 
 
EPHEDRINE USE: 
 This correlated well with the incidence of hypotension. 
 Group A(2.5mg) & group D(10mg) were similar in their ephedrine 
requirements with 10.8mg and 11.7mg mean respectively. 
 Group C(7.5mg) required an average of 5.7mg of ephedrine 
 Group B(5mg) required least amount of ephedrine which is about 
1.2mg. 
 
VOMITING: 
 Vomiting occurred mainly in Group D(10mg) & Group C(7.5mg) and 
the incidence is 20% & 35% respectively.  No vomiting was reported in 
2.5mg and 5 mg group patients. 
 This correlated with the study by Shou-Zen Fan et al
12
, where the 
incidence of vomiting is 10% & 20% in 7.5mg & 10mg groups of 0.5% 
bupivacaine respectively. 
 
 
 
 
 
SHIVERING: 
 Shivering occurred predominantly in group A(2.5mg) with an 
incidence of about 50%.  In other groups it was found to be insignificant. 
 This correlated with Shou-Zen Fan et al
12
 where the incidence of 
shivering was highest with 2.5mg group of 0.5% bupivacaine with 25% 
occurrence. 
 Thermoregulatory control was impaired during regional anaesthetic 
technique, where the thermoregulatory processing is similar between 
epidural and spinal anaesthesia (Osaki M et al
27
). 
  
The high incidence of shivering in 2.5 mg bupivacaine group when 
compared to all other groups might be due to 
- Large amount of epidural supplementation 
- The time taken to achieve adequate level of anaesthesia was high 
in 2.5mg bupivacaine group when compared to other groups. 
- High spinal level achieved immediately in 10mg and 7.5mg 
bupivacaine group, might have masked the shivering response in 
these parturients. 
 
 
DYSPNEA: 
 Dyspnea occurred in only one patient in group D(10mg). No 
occurrence in other groups.  This might probably be due to  
- High dose of the intrathecal bupivacaine used(10mg) 
- Height of that parturient was in the lower range of the groups(150 
cm) 
- Twin pregnancy, which increases the cephalad spread of the 
intrathecal drug faster due to epidural venous engorgement. 
The spread of spinal anaesthesia in singleton and twin pregnancies 
were compared in the study conducted by Jawan B et al
28
, where it was 
observed that fast onset and maximum cephalad spread was present among 
the twin pregnancies.  The twin pregnancy group had heavier, large uterus 
and very high production of progesterone when compared to singleton 
pregnancies, which resulted in higher level of blockade and respiratory 
problems in this group. 
 
 
 
 
 
SUMMARY 
 This double blinded prospective randomized controlled study was 
designed to evaluate the optimum dose of hyperbaric bupivacaine with 
epidural lignocaine necessary to produce adequate anaesthesia without 
hemodynamic instability in combined spinal epidural technique for 
caesarean section.  Four different doses of intrathecal hyperbaric 0.5% 
bupivacaine (2.5mg,5mg, 7.5mg & 10mg) were compared. 
 
 
The following observations were made: 
 
 Both 7.5mg and 10mg of 0.5% bupivacaine intrathecally produced 
adequate level of anaesthesia (T4) in most of the cases.  But the 
occurrence of hypotension and vomiting were very high in these 
groups. 
 2.5mg of 0.5% bupivacaine intrathecally produced a median sensory 
block level of T12, which required high doses of epidural 
supplementation of 2% lignocaine.  This resulted in high occurrence 
of hypotension and shivering. 
 
 5mg of 0.5% bupivacaine intrathecallyproduced adequate level of 
anaesthesia with minimal supplementation of epidural topup with 2% 
lignocaine.  The occurrence of hypotension, vomiting and shivering 
were very less compared to other groups. 
 There was no significant difference among the groups in terms of 
heart rate changes, quality of surgical anaesthesia and neonatal apgar 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 We conclude that 5mg of 0.5% bupivacaine intrathecally with 
minimal epidural lignocaine can produce adequate and rapid anaesthesia for 
caesarean section with minimal adverse effects. 
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PROFORMA 
 
NAME: PRIMI   /   G   P   L   A 
AGE: INDICATION FOR CAESAREAN: 
IP NO:  
GESTATIONAL AGE: SX : STARTING TIME: 
HT:         cm.         FINISHING TIME: 
WT:         kg. GROUP:    A  /  B  /  C  /  D 
 
EVENTS DRUGS TIME BP PR SpO2 IVF 
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
 
 
    GROUP A      
 SENSORY LEVEL 
AFTER 5 MINS: 
 2% LIGNOCAINE 
USED(total ml): 
 EPHEDRINE USED 
(total mg): 
 
 
 
 
 DYSPNEA 
 NAUSEA/ VOMITING 
 SHIVERING 
 OTHER COMP: 
 
 
 
 
 
 
 
 QUALITY OF 
SURGICAL 
ANAESTHESIA 
 
GOOD / MOD/ POOR 
 
 
 NEONATAL APGAR 
         1
ST
 MIN   -      /10 
         2
ND
 MIN  -      /10 
MASTER CHART 
 
 
 
 
     GROUP A BLOOD PRESSURE CHANGES   
               
          
NO. NAME AGE GA OC IND HT WT SL 2% LIG 
   wks   cms Kg 
10th 
min ml 
          
1 DEEPA 26 38 G2P1L1 PREV CS 154 54 T12 12 
2 VANITHA 26 39 G3P1L1 PREV CS 154 59 T12 12 
3 VIJI 22 38 PRIMI BREECH 158 54 T12 12 
4 ADHILAKSHMI 25 39 PRIMI CPD 158 58 T12 12 
5 SELVI 24 38 G3P1L1 PREV CS 161 56 L1 12 
6 JANAKI 20 38 PRIMI CPD 158 58 L1 12 
7 SARANYA  22 38 PRIMI CPD 150 52 T10 12 
8 GOWRI 30 38 G2P1L1 PREV CS 158 58 L1 15 
9 VANITHA RANI 25 38 PRIMI CPD 152 54 T10 12 
10 SHAKTHI 27 38 G2P1L1 PREV CS 158 53 L1 15 
11 RAJALAKSHMI 23 38 G3A2 PB 160 58 L1 12 
12 JOHARA 23 38 G2P1L1 BREECH 154 58 T12 9 
13 BHUVANESHWARI 25 38 G3P1L1 PREV CS 156 60 T12 12 
14 JAYAPRIYA 25 38 PRIMI TWIN 153 58 T12 12 
15 KAVITHA 27 38 G3P2L1 PREV CS 158 52 L1 15 
16 SUJATHA 27 38 G2P1L1 PREV CS 154 52 T12 9 
17 NAZEERA BEGAM 27 38 G3P1L1A1 PREV CS 156 54 T12 12 
18 SUNDARI 30 38 G4P3L1 PREV CS 155 58 T12 12 
19 ESTHER 29 38 G2P1L1 TWIN 154 52 T12 9 
20 PUSHPA 26 38 PRIMI CPD 156 57 T12 12 
          
          
NO. NAME EPH COMP OTHER DUR  MR NA NA PS 
  mg (D/NV/S) COMP min (G/M/P) 
1st 
min 
5th 
min (G/M/P) 
          
1 DEEPA 6 S  64 G 6 9 G 
2 VANITHA 6   70 G 6 9 G 
3 VIJI 18 S  64 G 5 8 G 
4 ADHILAKSHMI 12   62 G 5 8 G 
5 SELVI 12 S  68 G 5 9 G 
6 JANAKI 12   64 G 5 8 G 
7 SARANYA  12 S  64 G 6 9 G 
8 GOWRI 12 S  68 G 5 8 G 
9 VANITHA RANI 12 S  68 G 6 9 G 
10 SHAKTHI 12 S  70 G 5 8 G 
11 RAJALAKSHMI 12   66 G 5 8 G 
12 JOHARA 6   72 G 6 9 G 
13 BHUVANESHWARI 6 S  54 G 5 8 G 
14 JAYAPRIYA 12   62 G 6 9 G 
15 KAVITHA 18 S  64 G 5 8 G 
16 SUJATHA 6   74 G 6 9 G 
17 NAZEERA BEGAM 6   56 G 5 8 G 
18 SUNDARI 12   62 G 5 8 G 
19 ESTHER 12   68 G 6 9 G 
20 PUSHPA 12 S  64 G 5 8 G 
 base line 1st min 2nd min 5th  min 10th min 15th min 20th min 
 sys dias sys dias sys dias sys dias sys dias sys dias sys dias 
               
1 130 80 130 80 124 80 122 78 110 74 94 70 112 72 
2 122 70 120 70 105 64 105 64 92 62 112 70 114 74 
3 108 70 108 70 108 68 104 68 82 58 84 58 92 58 
4 110 72 110 72 112 72 112 72 80 60 76 58 94 60 
5 112 72 112 72 112 72 112 72 82 60 78 58 94 60 
6 132 76 132 76 130 70 128 70 112 70 100 64 82 62 
7 100 64 100 64 98 64 100 64 92 60 80 54 82 54 
8 116 70 116 70 114 70 124 70 118 64 82 52 78 52 
9 108 70 108 70 104 70 98 70 98 70 94 70 94 64 
10 122 68 122 68 124 68 120 68 116 64 114 64 88 56 
11 128 76 128 76 124 76 124 70 116 68 108 64 86 56 
12 120 80 120 80 118 80 104 76 100 76 88 70 96 72 
13 124 74 124 74 122 74 118 70 118 70 98 68 86 64 
14 122 72 122 72 112 70 110 70 108 70 90 62 108 70 
15 112 68 112 68 110 68 110 62 110 62 82 56 84 56 
16 134 70 130 70 122 62 112 60 110 60 92 70 110 70 
17 132 64 132 60 134 64 124 70 118 70 94 70 112 74 
18 110 68 110 68 108 68 120 68 118 68 82 56 82 58 
19 118 74 118 74 112 74 126 80 122 80 80 60 82 60 
20 120 70 120 70 130 72 132 72 128 70 108 70 84 60 
               
               
 25th min 30th min 40th min 50th min 60th min     
 sys dias sys dias sys dias sys dias sys dias     
               
1 112 74 114 74 118 74 120 74 120 74     
2 114 78 120 78 120 78 122 78 130 80     
3 98 58 98 60 98 60 100 60 102 60     
4 94 64 98 64 98 64 98 70 98 70     
5 94 60 98 64 98 62 100 70 100 70     
6 80 62 98 64 108 68 108 68 110 68     
7 96 60 96 60 104 60 108 62 108 62     
8 98 52 98 54 100 54 100 56 108 56     
9 84 62 84 62 98 70 98 70 112 70     
10 84 56 112 60 112 60 124 64 124 64     
11 86 56 98 60 112 64 114 64 128 64     
12 96 74 112 76 112 76 118 76 126 78     
13 114 68 114 70 114 70 118 70 120 70     
14 110 72 110 72 114 74 122 74 124 78     
15 86 58 112 68 112 70 112 70 112 74     
16 112 74 124 74 124 74 124 74 124 74     
17 120 76 120 76 124 76 124 78 124 78     
18 94 70 94 72 100 70 100 70 112 74     
19 100 64 100 64 108 64 108 64 110 64     
20 82 58 98 72 98 72 104 72 104 74     
 
 
 
   GROUP A  HEART RATE CHANGES    
             
 base 1st 2nd 5th 10th 15th 20th 25th 30th 40th 50th 60th 
 line min min min min min min min min min min min 
             
1 64 62 54 54 50 52 52 54 54 52 52 52 
2 60 60 54 54 52 54 56 60 56 56 58 62 
3 70 72 70 68 64 67 68 68 64 66 68 70 
4 98 94 70 72 72 74 74 66 72 72 78 74 
5 62 64 64 62 58 54 54 56 58 56 54 56 
6 78 74 72 64 64 62 64 64 62 60 64 64 
7 90 84 72 70 64 68 64 68 68 72 72 78 
8 82 80 74 72 74 70 74 78 77 72 73 74 
9 72 70 78 56 52 56 54 54 58 60 65 64 
10 56 54 52 54 50 52 52 60 54 56 58 58 
11 62 62 62 62 60 56 58 58 54 54 54 56 
12 94 92 84 76 64 65 64 62 58 64 64 62 
13 64 62 60 58 54 54 54 52 50 54 58 56 
14 77 74 62 62 64 64 56 58 57 54 64 64 
15 82 78 78 74 74 72 62 52 52 52 58 60 
16 62 62 54 52 50 52 52 54 54 51 52 54 
17 58 60 52 54 52 54 56 60 56 56 58 64 
18 72 70 70 68 63 67 68 68 66 66 68 70 
19 94 94 70 70 72 74 74 66 72 70 78 74 
20 67 64 64 62 58 54 54 56 58 54 54 56 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    GROUP B     
          
NO. NAME AGE GA OC IND HT WT SL 2% LIG 
   wks   cms Kg 
10th 
min ml 
          
1 UNNAMALAI 21 38 G2P1L1 PREV CS 153 52 T6 3 
2 VIDHYA 28 38 G2P1L1 PREV CS 160 56 T6 6 
3 VALLI 26 37 PRIMI CPD 154 52 T6 6 
4 PAVEENA 22 38 PRIMI CPD 152 54 T4 0 
5 SARASWATHI 23 38 G2P1L1 PREV CS 152 54 T4 0 
6 
SHAMED 
FAKHIYA 25 38 G2P1L1 PREV CS 156 54 T6 6 
7 PARVATHY 25 38 G2P1L1 PREV CS 154 52 T6 6 
8 REVATHI 25 38 G3P1L1A1 CPD 156 58 T6 6 
9 RENUKA DEVI 23 38 PRIMI CPD 154 54 T6 6 
10 FAREEDA 23 38 G2P1L1 PREV CS 154 52 T4 0 
11 AMUTHA SELVI 27 38 G3P1L1A1 PREV CS 158 54 T10 12 
12 RATHI 23 38 G2P1L0 PREV CS 152 56 T4 0 
13 THULASI 23 38 G2P1L1 PREV CS 158 56 T8 6 
14 FATHIMA 30 38 G2P1L1 PREV CS 154 56 T6 6 
15 SUGANTHI 22 38 G2P1L1 PREV CS 158 57 T6 6 
16 SUDHA 30 38 G3P1L1A1 PREV CS 158 57 T6 6 
17 NITHYA 23 38 G2P1L1 PREV CS 159 59 T4 0 
18 JAYA 24 38 PRIMI CPD 152 52 T6 3 
19 PARIMALA 30 38 G2P1L1 PREV CS 159 58 T6 6 
20 KAUSAR 30 38 G3P1L1 PREV CS 158 60 T8 6 
          
          
NO. NAME EPH COMP OTHERS DUR  MR NA NA PS 
  mg (D/NV/S) COMP min (G/M/P) 
1st 
min 
5th 
min (G/M/P) 
          
1 UNNAMALAI 0   74 G 5 9 G 
2 VIDHYA 0   64 G 5 8 G 
3 VALLI 0   64 G 5 9 G 
4 PAVEENA 6   64 G 5 9 G 
5 SARASWATHI 6   64 G 5 9 G 
6 
SHAMED 
FAKHIYA 0   54 G 6 8 G 
7 PARVATHY 0   62 G 6 9 G 
8 REVATHI 0   60 G 6 9 G 
9 RENUKA DEVI 0   54 G 6 9 G 
10 FAREEDA 0   58 G 6 8 G 
11 AMUTHA SELVI 12 S  78 G 6 9 G 
12 RATHI 0   72 G 5 9 G 
13 THULASI 0   64 G 6 9 G 
14 FATHIMA 0   52 G 6 8 G 
15 SUGANTHI 0   68 G 6 9 G 
16 SUDHA 0   70 G 6 8 G 
17 NITHYA 0   62 G 6 8 G 
18 JAYA 0   70 G 5 9 G 
19 PARIMALA 0   60 G 5 8 G 
20 KAUSAR 0   64 G 6 8 G 
 
     GROUP B BLOOD PRESSURE CHANGES    
               
 base line 1st min 2nd min 5th  min 10th min 15th min 20th min 
 sys dias sys dias sys dias sys dias sys dias sys dias sys dias 
               
1 124 70 124 70 122 70 100 68 96 68 98 66 98 64 
2 118 68 118 68 124 72 108 68 104 64 98 70 98 70 
3 128 68 130 68 134 68 112 68 108 68 104 64 102 64 
4 132 70 144 74 144 78 92 70 112 68 108 68 110 68 
5 112 70 112 70 120 74 80 64 94 70 94 70 110 72 
6 124 72 124 74 132 70 120 70 110 70 112 74 108 74 
7 120 74 120 74 124 74 108 70 108 70 104 70 104 70 
8 130 80 130 80 124 74 112 74 108 70 108 70 108 74 
9 112 70 112 70 110 70 98 70 98 70 100 72 102 72 
10 132 70 130 70 134 72 110 64 108 62 104 60 104 60 
11 122 90 122 90 134 92 128 90 122 90 118 94 104 78 
12 124 70 124 70 128 70 100 70 100 68 100 68 104 70 
13 120 70 120 70 118 70 94 70 94 70 98 70 98 72 
14 132 82 132 82 130 82 112 74 112 74 108 70 108 70 
15 110 70 110 70 118 70 92 64 94 64 108 68 108 68 
16 108 74 108 74 110 74 90 70 92 72 100 70 98 70 
17 114 78 114 78 124 78 94 70 96 70 100 72 100 74 
18 124 70 124 70 124 70 108 64 108 68 104 64 104 64 
19 128 90 120 90 130 90 104 90 104 90 108 92 104 84 
20 106 74 104 64 106 64 92 56 92 56 94 56 94 56 
               
               
 25th min 30th min 40th min 50th min 60th min     
 sys dias sys dias sys dias sys dias sys dias     
               
1 98 64 100 68 100 68 104 64 104 68     
2 100 70 100 74 100 74 104 74 98 70     
3 112 64 112 64 118 64 120 70 120 70     
4 108 70 118 68 118 68 120 70 120 70     
5 108 70 108 72 112 74 120 74 112 74     
6 108 74 112 70 112 70 120 74 122 74     
7 112 72 112 72 112 74 112 78 124 78     
8 110 72 110 72 112 74 114 74 128 74     
9 102 70 108 74 108 74 110 74 112 78     
10 104 64 118 70 118 70 120 70 120 74     
11 86 64 84 64 110 70 110 70 124 70     
12 104 70 104 74 104 72 108 70 108 72     
13 100 74 104 74 104 74 110 78 108 78     
14 110 74 110 74 118 80 118 74 120 80     
15 108 70 108 70 110 70 110 70 112 74     
16 98 72 98 74 94 70 92 70 98 74     
17 104 78 104 78 108 78 112 78 112 78     
18 102 64 108 68 108 68 110 68 110 68     
19 104 84 110 84 110 84 110 84 112 84     
20 94 56 98 56 98 58 100 62 100 62     
 
 
 
 
   GROUP B HEART RATE CHANGES     
             
 base 1st 2nd 5th 10th 15th 20th 25th 30th 40th 50th 60th 
 line min min min min min min min min min min min 
             
1 76 74 62 60 64 64 56 58 54 54 64 64 
2 80 78 76 74 74 70 62 52 52 52 58 62 
3 72 70 70 68 63 67 68 68 62 66 68 70 
4 64 62 62 60 58 58 62 60 58 54 52 56 
5 60 62 54 52 50 52 52 54 54 51 52 56 
6 60 60 52 54 50 54 56 60 56 54 58 62 
7 74 70 70 68 63 67 68 68 64 66 68 70 
8 94 94 70 70 72 74 72 66 70 70 78 72 
9 68 64 64 62 58 54 54 56 58 54 54 54 
10 70 70 70 62 63 64 68 62 64 66 68 70 
11 74 72 68 68 64 58 54 54 52 58 60 68 
12 92 84 72 70 64 68 64 68 68 72 72 78 
13 82 80 74 72 74 70 74 78 77 72 73 74 
14 70 70 78 56 52 56 54 54 58 63 65 64 
15 60 62 62 62 60 56 58 58 54 54 54 56 
16 92 92 84 76 64 65 64 62 56 64 64 62 
17 62 62 60 58 54 52 54 52 50 54 58 56 
18 90 84 72 70 68 68 64 68 64 72 72 78 
19 80 82 74 72 74 72 74 77 77 72 73 74 
20 82 80 74 66 64 62 56 58 62 62 61 60 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    GROUP C      
          
NO. NAME AGE GA OC IND HT WT SL 2% LIG 
   wks   cms Kg 
10th 
min ml 
          
1 SUMATHY 21 37 PRIMI CPD 156 52 T4 0 
2 SURYA 21 38 PRIMI BREECH 156 52 T8 6 
3 RAJESHWARI 20 38 PRIMI BREECH 156 60 T4 0 
4 ANJALAI 20 38 PRIMI CPD 153 54 T4 0 
5 NAGAJOTHI 26 38 PRIMI CPD 156 54 T4 0 
6 UDAYALAKSHMI 26 38 G3P2L2 PREV CS 152 54 T4 0 
7 POONGODHAI 26 38 PRIMI CPD 154 54 T4 0 
8 ALAMELU 25 38 G2P1L1 PREV CS 159 56 T4 0 
9 INDHUMATHY  29 38 G3P1L1A1 PREV CS 154 60 T4 0 
10 CHELLAPRIYA 27 38 PRIMI CPD 154 53 T4 0 
11 GOPIRANI 25 38 G2P1L1 PREV CS 159 54 T4 0 
12 SANKARI 23 38 G2P1L1 PREV CS 158 58 T4 0 
13 DHANALAKSHMI 29 38 G2P1L1 PREV CS 157 54 T4 0 
14 SELVI 24 38 G3P1L1A1 PREV CS 158 56 T4 0 
15 AMULU 25 38 G3P2L2 PREV CS 156 54 T4 0 
16 USHA 25 38 G2P1L1 PREV CS 154 56 T4 0 
17 SHAMEEM 29 38 G2P1L1 PREV CS 158 56 T4 0 
18 SHENBAGAVALLI 30 38 PRIMI CPD 156 54 T8 6 
19 RANI 30 38 G3P2L2 PREV CS 156 55 T4 0 
20 SHYAMALA DEVI 24 38 G2P1L1 PREV CS 159 58 T10 12 
          
          
NO. NAME EPH COMP OTHERS DUR  MR NA NA PS 
  mg (D/NV/S) COMP min (G/M/P) 
1st 
min 5th min (G/M/P) 
          
1 SUMATHY 0   54 G 5 9 G 
2 SURYA 6   54 G 5 9 G 
3 RAJESHWARI 12 NV  52 G 6 9 G 
4 ANJALAI 12 NV  54 G 5 8 G 
5 NAGAJOTHI 0   58 G 6 9 G 
6 UDAYALAKSHMI 12 NV  68 G 5 8 G 
7 POONGODHAI 6   52 G 5 8 G 
8 ALAMELU 6   72 G 5 8 G 
9 INDHUMATHY  6   60 G 5 8 G 
10 CHELLAPRIYA 6   64 G 5 8 G 
11 GOPIRANI 0   74 G 5 8 G 
12 SANKARI 6   62 G 6 9 G 
13 DHANALAKSHMI 6   50 G 6 9 G 
14 SELVI 6   64 G 6 8 G 
15 AMULU 12   56 G 6 9 G 
16 USHA 0   64 G 5 8 G 
17 SHAMEEM 0   70 G 5 8 G 
18 SHENBAGAVALLI 6   54 G 6 9 G 
19 RANI 0   54 G 6 9 G 
20 SHYAMALA DEVI 12 S/NV  80 G 5 8 G 
 
     GROUP C BLOOD PRESSURE CHANGES   
               
 base line 1st min 2nd min 5th  min 10th min 15th min 20th min 
 sys dias sys dias sys dias sys dias sys dias sys dias sys dias 
               
1 124 70 124 70 128 70 100 70 100 68 100 68 104 70 
2 128 70 120 72 124 72 118 70 108 68 104 64 86 56 
3 122 70 122 70 128 74 82 64 94 70 82 62 98 68 
4 130 92 130 92 130 94 108 82 94 70 82 68 102 70 
5 120 74 120 74 124 74 108 70 108 70 104 70 104 70 
6 108 80 108 80 110 80 84 64 82 62 108 74 112 74 
7 116 74 116 74 114 74 84 56 94 70 94 70 96 70 
8 132 94 132 92 124 90 100 80 84 64 100 70 100 70 
9 126 84 126 84 128 84 108 70 88 62 94 64 94 64 
10 124 74 124 74 124 74 82 60 98 62 98 64 98 66 
11 130 82 132 82 130 82 112 74 112 74 108 70 108 70 
12 106 70 106 70 104 70 80 60 94 60 94 60 98 64 
13 112 78 112 78 120 78 78 56 92 60 94 60 100 64 
14 124 72 124 72 128 72 88 64 98 64 98 64 100 64 
15 110 70 110 70 112 70 76 54 82 58 94 70 94 70 
16 118 68 118 68 124 72 108 68 104 64 98 70 98 70 
17 128 68 130 68 134 68 112 68 108 68 104 64 102 64 
18 114 68 114 70 114 70 84 58 94 60 94 60 98 62 
19 112 70 112 70 110 70 98 70 98 70 100 72 102 72 
20 108 74 108 74 104 74 82 56 84 56 92 60 94 60 
               
               
 25th min 30th min 40th min 50th min 60th min     
 sys dias sys dias sys dias sys dias sys dias     
               
1 104 70 104 74 104 72 108 70 108 72     
2 100 60 102 62 104 62 104 64 108 68     
3 100 70 100 74 108 74 108 78 110 78     
4 102 74 108 74 108 78 112 78 120 78     
5 112 72 112 72 112 74 112 78 124 78     
6 112 78 118 80 118 80 124 82 124 80     
7 98 72 98 74 100 74 100 74 108 74     
8 102 70 102 72 102 74 102 74 108 74     
9 98 64 98 64 100 68 100 68 112 68     
10 100 66 108 70 112 74 124 76 124 78     
11 110 74 110 74 118 80 118 74 120 80     
12 98 64 108 64 108 68 110 68 110 70     
13 104 64 104 64 108 64 108 64 110 64     
14 100 68 104 68 108 68 112 70 118 70     
15 98 70 98 72 102 72 104 72 112 74     
16 100 70 100 74 100 74 104 74 98 70     
17 112 64 112 64 118 64 120 70 120 70     
18 98 64 98 64 102 70 112 70 124 70     
19 102 70 108 74 108 74 110 74 112 78     
20 94 60 100 64 108 68 120 70 124 74     
 
 
 
   GROUP C HEART RATE CHANGES     
             
 base 1st 2nd 5th 10th 15th 20th 25th 30th 40th 50th 60th 
 line min min min min min min min min min min min 
             
1 82 80 78 64 64 62 62 60 62 60 64 68 
2 84 84 80 70 64 62 62 58 58 54 64 68 
3 74 74 72 64 62 62 54 54 52 56 58 58 
4 72 72 74 62 66 62 60 62 64 62 62 64 
5 78 74 72 64 64 62 64 64 62 60 64 64 
6 92 84 72 70 68 68 64 68 68 72 72 78 
7 84 82 74 72 74 72 74 78 77 72 73 74 
8 81 80 74 66 64 62 56 58 62 62 61 60 
9 78 74 64 66 67 68 67 68 70 68 65 66 
10 64 62 54 52 50 52 52 54 54 51 52 52 
11 60 60 54 54 52 54 56 60 56 56 58 62 
12 72 72 70 68 66 67 68 68 66 66 68 70 
13 98 94 70 72 72 74 74 66 72 72 78 78 
14 68 64 64 62 58 58 54 56 58 58 54 56 
15 70 70 78 56 54 56 54 54 58 60 65 64 
16 54 54 52 50 50 52 52 60 54 56 58 58 
17 64 62 62 60 60 56 58 58 54 52 54 56 
18 98 92 84 76 64 65 64 62 58 64 64 62 
19 62 62 60 58 54 56 54 52 50 54 56 58 
20 77 74 62 62 64 64 56 58 57 58 64 64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    GROUP D      
          
NO. NAME AGE GA OC IND HT WT SL 2% LIG 
   wks   cms Kg 
10th 
min ml 
          
1 MAHESHWARI 32 38 G2P1L1 PREV CS 154 52 T4 0 
2 UMA 28 38 G3P1L1A1 PREV CS 155 54 T4 0 
3 VIDHYA 28 38 G2P1L1 PREV CS 160 54 T4 0 
4 JAYASREE 21 38 G2P1L1 PREV CS 159 59 T4 0 
5 AMBULI 28 38 G2P1L1 PREV CS 158 58 T4 0 
6 SHENBAGAM 22 38 G2P1L1 PREV CS 162 53 T4 0 
7 KAREENA 26 38 G3P2L1 PREV CS 160 56 T4 0 
8 SUGANYA 22 38 G2P1L1 PREV CS 155 56 T4 0 
9 DHANAM 27 38 G2P1L1 PREV CS 154 56 T4 0 
10 PRIYADARSHINI 23 38 PRIMI TWIN 150 54 T4 0 
11 MARIAMMAL 22 38 G3P1L1A1 PREV CS 153 56 T4 0 
12 KAVITHA 21 38 G2P1L1 PREV CS 154 57 T4 0 
13 VELLATHAI 25 38 G2P1L1 PREV CS 154 54 T4 0 
14 SILAMBARASI 25 38 G3P2L2 PREV CS 152 56 T4 0 
15 PRIYA  23 38 G2P1L1 PREV CS 155 58 T4 0 
16 VELANKANI 23 38 G2P1L1 PREV CS 156 52 T4 0 
17 RAHIM BEEVI 25 38 G3P2L2 PREV CS 154 54 T4 0 
18 MALLIGA 28 38 G3P2L2 PREV CS 154 56 T4 0 
19 UMA MAHESHWARI 25 38 G2P1L1 PREV CS 157 56 T4 0 
20 PRIYADARSHINI 30 38 G3P2L2 PREV CS 160 57 T4 0 
          
          
NO. NAME EPH COMP OTHERS DUR  MR NA NA PS 
  mg (D/NV/S) COMP min (G/M/P) 
1st 
min 5th min (G/M/P) 
          
1 MAHESHWARI 12   52 G 5 8 G 
2 UMA 6   60 G 6 9 G 
3 VIDHYA 12   62 G 5 9 G 
4 JAYASREE 12 NV  62 G 6 9 G 
5 AMBULI 12   64 G 6 9 G 
6 SHENBAGAM 6   56 G 5 9 G 
7 KAREENA 12   60 G 5 9 G 
8 SUGANYA 18 NV  62 G 6 9 G 
9 DHANAM 18 NV  56 G 5 8 G 
10 PRIYADARSHINI 18 D/NV  70 G 5 8 G 
11 MARIAMMAL 12 NV  52 G 5 8 G 
12 KAVITHA 12   56 G 5 8 G 
13 VELLATHAI 6   54 G 5 8 G 
14 SILAMBARASI 18 NV  64 G 5 8 G 
15 PRIYA  12   64 G 6 9 G 
16 VELANKANI 12 NV  68 G 6 9 G 
17 RAHIM BEEVI 12   52 G 6 8 G 
18 MALLIGA 12   56 G 6 9 G 
19 UMA MAHESHWARI 6   70 G 6 9 G 
20 PRIYADARSHINI 6   62 G 5 9 G 
 
 
     GROUP D BLOOD PRESSURE CHANGES     
               
 base line 1st min 2nd min 5th  min 10th min 15th min 20th min 
 sys dias sys dias sys dias sys dias sys dias sys dias sys dias 
               
1 124 82 124 82 124 82 82 64 84 64 92 64 94 68 
2 114 80 114 80 114 80 102 68 94 68 84 64 94 70 
3 112 70 112 70 112 70 86 56 98 56 102 56 84 54 
4 130 84 130 84 132 84 104 64 88 64 98 70 84 60 
5 132 82 132 82 132 82 110 78 102 74 86 58 84 58 
6 124 80 124 80 122 80 94 70 84 68 94 68 94 68 
7 128 84 128 84 124 84 102 70 86 64 114 72 110 70 
8 104 70 104 70 120 70 78 56 82 56 80 56 94 58 
9 104 74 104 74 108 74 90 60 84 56 82 54 88 56 
10 124 78 124 78 124 78 104 70 98 68 84 62 82 62 
11 126 74 126 74 126 74 108 70 84 60 94 62 94 62 
12 116 78 116 78 118 78 78 54 82 56 102 70 102 70 
13 122 82 122 82 122 82 84 64 108 70 108 70 104 70 
14 118 74 118 74 120 74 102 70 78 56 82 58 94 54 
15 116 78 116 78 118 78 102 70 94 70 86 64 82 64 
16 108 72 108 72 108 72 78 50 82 54 98 70 98 70 
17 122 74 122 74 124 74 80 56 84 56 98 70 98 70 
18 116 78 116 78 116 78 102 64 82 60 82 60 94 60 
19 104 74 104 74 108 74 84 60 94 62 94 62 94 64 
20 130 84 130 84 132 84 80 56 102 60 102 68 112 70 
               
               
 25th min 30th min 40th min 50th min 60th min     
 sys dias sys dias sys dias sys dias sys dias     
               
1 98 70 98 70 102 70 108 70 120 74     
2 `118 70 118 70 120 74 124 74 124 78     
3 110 64 110 68 112 68 120 70 124 74     
4 104 74 104 78 108 78 120 80 124 80     
5 104 60 104 64 110 70 110 72 118 74     
6 100 72 104 74 104 78 110 78 112 80     
7 84 60 112 64 118 68 124 70 124 74     
8 94 60 98 60 100 64 104 64 104 68     
9 94 60 94 62 98 64 100 70 110 72     
10 112 74 88 60 120 78 114 74 118 78     
11 98 64 100 64 108 70 108 72 116 74     
12 104 70 112 74 118 74 124 74 124 74     
13 124 78 124 78 130 80 132 80 134 84     
14 80 50 100 64 100 66 114 70 114 74     
15 98 68 98 70 100 70 104 74 104 74     
16 100 74 110 74 112 74 112 78 120 78     
17 104 70 104 74 110 74 132 74 134 82     
18 94 64 106 64 106 68 112 74 112 74     
19 98 64 98 64 100 64 100 64 104 64     
20 112 74 112 74 120 78 124 78 124 78     
 
 
 
 
 
   GROUP D HEART RATE CHANGES     
             
 base 1st 2nd 5th 10th 15th 20th 25th 30th 40th 50th 60th 
 line min min min min min min min min min min min 
             
1 68 68 64 62 60 62 62 54 52 56 54 54 
2 90 84 72 70 64 68 64 68 68 70 72 78 
3 80 80 74 72 74 70 74 78 77 72 73 74 
4 70 70 78 56 52 56 54 54 58 65 65 64 
5 64 62 62 62 60 56 58 58 54 54 54 56 
6 92 92 84 76 64 65 64 62 58 62 64 62 
7 64 62 60 58 54 54 54 52 50 52 58 56 
8 64 62 60 58 54 52 54 56 58 58 60 62 
9 74 72 68 64 62 60 60 58 58 64 62 64 
10 84 82 72 64 58 52 50 48 48 54 50 58 
11 98 94 70 72 72 74 74 66 72 72 78 78 
12 68 64 64 62 58 58 54 56 58 58 54 54 
13 70 70 78 56 54 56 54 54 58 60 65 62 
14 60 60 56 54 48 50 50 50 58 58 54 60 
15 98 94 70 72 72 74 74 66 72 72 78 72 
16 60 64 64 62 58 54 54 56 58 56 54 54 
17 74 74 72 64 64 62 64 64 62 60 64 62 
18 60 62 60 58 54 52 54 52 50 54 58 54 
19 92 84 72 70 68 68 64 68 64 72 72 74 
20 82 82 74 72 74 72 74 77 77 72 73 72 
 
 
 
 
 
 
 
 
 
 
 
 
